Tables
- TABLE 1
Clinical characteristics of patients with Vα2.3+ T-cells >10.5% in bronchoalveolar lavage fluid (BALF)
LS Non-LS Subjects 180 68 Male/female 111/69 41/27 Age years# 37 (21–62) 45 (26–72) Radiographic stage 0/I/II/III/IV# 0/123/57/0/0 4/16/36/8/4 Resolving/non-resolving# 166/14 25/43 CD4/CD8 ratio* 9.8 (0.9–56.8) 7.1 (1.2–24.0) % Vα2.3 BALF cells# 28.4 (11.0–50.0) 17.8 (11.4–44.3) HLA-DRB1*03+/− 155/25 36/32 Vα2.3 BALF cells % HLA-DRB1*03+# 29.9 20.5 HLA-DRB1*03−** 19.8 14.8 Patients recovered % HLA-DRB1*03+# 94 39 HLA-DRB1*03−** 80 34 Data are presented as n or mean (range), unless otherwise stated. LS: Löfgreńs syndrome. *: p<0.05, **: p<0.001 and #: p<0.0001, comparing differences between patients with LS and non-LS and for radiological stage differences between stage I and II.
Supplementary Materials
Supplementary Material
This one-page PDF can be shared freely online.
Shareable PDF ERJ-01450-2019.Shareable
Vol 55 Issue 1
Table of Contents
Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis
